Amid worldwide regulatory bans on growth-promoting antibiotics, livestock and aquaculture face intense superbug pressure. The World Organisation for Animal Health (WOAH), FAO, and WHO increasingly champion bacteriophages as prime targeted non-antibiotic alternatives that eliminate pathogenic bacteria without triggering collateral antimicrobial resistance.
Export aquaculture operators—from white shrimp to tilapia and eel—face increasingly stringent international testing standards with near-zero tolerance for drug residues. New-Line Bio’s marine phage cocktails provide targeted Vibrio and Aeromonas clearance, ensuring safe export compliance and superior harvest survival.
Repeated national food inspection bulletins highlighting veterinary antibiotic residues in eggs, poultry, and aquaculture have shaken consumer trust. Green bio-solutions utilizing virulent bacteriophages provide agricultural enterprises with zero-withdrawal, residue-free biological barriers from breeding to slaughter.
Combining host-specific lytic phages with probiotic Bacillus subtilis creates powerful symbiotic synergy: while bacteriophages swiftly decimate enteric pathogen loads (Salmonella, E. coli, Clostridium), Bacillus subtilis rapidly colonizes mucosal niches, secretes digestive enzymes, and accelerates epithelial villus regeneration to optimize feed conversion.
Staphylococcus aureus causes pervasive subclinical mastitis in dairy herds, bumblefoot and gangrenous dermatitis in poultry, and enterotoxin food poisoning. New-Line Bio’s lytic phage and endolysin pipeline offers selective biocontrol that eradicates resistant biofilms across production chains.
Cutting-edge research published in Cell Host & Microbe reveals that bacteriophages in the human gut microbiome act as upstream orchestrators of gut-brain axis signaling. By selectively pruning inflammatory bacteria that disrupt tryptophan and serotonin metabolism, phages represent a revolutionary frontier in psychomicrobiology and metabolic health.
As AI evolves from scientific novelty into ubiquitous infrastructure, modern phage biology is undergoing a profound paradigm shift. New-Line Bio integrates machine learning with our "Three Libraries, One Platform" architecture, leveraging generative models and protein structural prediction to accelerate lytic enzyme discovery, receptor binding protein (RBP) optimization, and broad-host-range cocktail engineering.